Novo Nordisk's weight loss injection cut obesity in young children, trial shows
In the STEP Young trial, BMI fell an estimated 17.4% with semaglutide and rose 2.2% with placebo at week 68 among children 6 to under 12
In the STEP Young trial, BMI fell an estimated 17.4% with semaglutide and rose 2.2% with placebo at week 68 among children 6 to under 12